Article Detail - JE Part A
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R13 - Effective January 25, 2024
Date Posted: January 25, 2024
This coverage article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: January 25, 2024
Summary of Article Changes:
Under Article Text subheading Billing Instructions revised 1st paragraph to add "For Part B paper claims, the drug or drugs in consideration for use that require the use of the pharmacogenomics (PGx) test must be submitted in Item 19 field." This revision is effective 1/25/2024.
Under CPT/HCPCS Group 1: Codes added 0380U. This revision is due to new covered panel that has successfully completed a TA and is effective 5/11/2023.
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
